-
Product Insights
New![]()
Net Present Value Model: Mustang Bio Inc’s MB-107
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Mustang Bio Inc’s MB-106
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Clay Dev & Const – Mustang Ridge Distribution Center II – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our Clay Dev & Const – Mustang Ridge Distribution Center II – Texas report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:Dive...
-
Product Insights
Invenergy – Mustang Mile Solar Energy Facility 150MW – Michigan
Equip yourself with the essential tools needed to make informed and profitable decisions with our Invenergy - Mustang Mile Solar Energy Facility 150MW - Michigan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Thakkar Dev – Mustang Square Mixed-Use Development – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our Thakkar Dev - Mustang Square Mixed-Use Development - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
TradeWind Energy – Mustang Run Wind Farm 136 MW – Oklahoma
Equip yourself with the essential tools needed to make informed and profitable decisions with our TradeWind Energy - Mustang Run Wind Farm 136 MW - Oklahoma report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Xcel Energy – Western Mustang Solar Farm 74 MW – Wisconsin
Equip yourself with the essential tools needed to make informed and profitable decisions with our Xcel Energy - Western Mustang Solar Farm 74 MW - Wisconsin report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Goldman Sachs Asset – Mustang Battery Energy Storage System 75 MW – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Goldman Sachs Asset - Mustang Battery Energy Storage System 75 MW - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
New![]()
Net Present Value Model: Calliditas Therapeutics AB’s Setanaxib
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Intra-Cellular Therapies Inc’s Lenrispodun phosphate
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MB-103 in Brain Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.MB-103 in Brain CancerDrug Details:MB-103 is under development for the treatment of glioblastoma multiforme, breast cancer...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BNT-161 in Influenzavirus B Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BNT-161 in Influenzavirus B Infections Drug Details:BNT-161 is under development for the prevention of seasonal influenza,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MB-107 in X-Linked SCID
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.MB-107 in X-Linked SCIDDrug Details:MB-107 is under development for the treatment of X-linked severe combined immunodeficiency....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BAT-6026 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BAT-6026 in Solid Tumor Drug Details: BAT-6026 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Thrombosomes in Hemostasis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Thrombosomes in Hemostasis Drug Details: Thrombosomes is under development for the treatment of wounds...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CN-201 in Diffuse Large B-Cell Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CN-201 in Diffuse Large B-Cell Lymphoma Drug Details:CN-201 is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Monoclonal Antibody Conjugate To Target Gpc1 For Oncology in Metastatic Transitional (Urothelial) Tract Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Monoclonal Antibody Conjugate To Target Gpc1 For Oncology in Metastatic Transitional (Urothelial) Tract Cancer Drug Details:Monoclonal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MB-105 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.MB-105 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:MB-105 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Iscalimab in Sicca Syndrome (Sjogren)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Iscalimab in Sicca Syndrome (Sjogren) Drug Details: Iscalimab is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MB-103 in Glioblastoma Multiforme (GBM)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.MB-103 in Glioblastoma Multiforme (GBM)Drug Details:MB-103 is under development for the treatment of glioblastoma multiforme, breast...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.